28
Views
4
CrossRef citations to date
0
Altmetric
Research Article

An Examination of Serial Urinalyses in Patients with North American Crotalid Envenomation

, , , , &
Pages 329-335 | Published online: 25 Sep 2008

References

  • Russell F. E., Carlson R. W., Wainschel J. Snake venom poisoning in the Unites States: Experiences with 550 cases. JAMA 1975; 233: 341–344
  • Wingert W. A., Chan L. Rattlesnake bites in southern California and rationale for recommended treatment. West J Med 1988; 148: 37–44
  • Parrish HM. Incidence of treated snakebites in the Unites States. Public Health Rep 1966; 81: 269–276
  • Tin-Nu-Swe, Tin-Tun, Myint-Lwin. Renal isch-aemia, transient glomerular leak and acute renal tubular damage in patients envenomated by Russell's vipers (Daboia russelii siamensis) in Myanmar. Transactions Royal Soc Trop Med Hyg 1993; 87: 678–681
  • Dart R. C., Siefert S. A., Carroll L., Clark R. F. Human trial of an affinity purified antibody fragment for snake venom poisoning. Vet Human Toxicol Urinalysis After Rattlesnake Bites 335 1994; 36: 363
  • Dart R. C., Seifert S. A., Carroll L., Clark RF, Hall E., Boyer-Hassen L. V., Curry S. C., Kitchens CS. Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning. Ann Emerg Med 1997; 30: 33–39
  • Dart R. C., Hurlbut K. M., Garcia R. Validation of a severity score for the assessment of crotalid snakebite. Ann Emerg Med 1996; 27: 321–326
  • Bush S. P., Jansen PW. Severe rattlesnake envenom-ation with anaphylaxis and rhabdomyolysis. Ann Emerg Med 1995; 25: 845–848
  • Burdmann E. A., Woronik V., Prado E. BA. Snakebite-induced acute renal failure: an experimental model. Am J Trop Med Hyg 1993; 48: 82–88
  • Keyler D. E., Salerno D. M., Murakami M. M. Rapid administration of high-dose human antibody Fab fragments to dogs: Pharmacokinetics and toxicity. Fund Appl Toxicol 1991; 17: 83–91
  • Pentel P. R., Keyler D. E., Gilbertson D. G. Pharmacokinetics and toxicity of high doses of antibody Fab fragments in rats. Drug Metab Dispos 1988; 16: 141–145

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.